Drawing for GREEN BIOWORKS

USPTO serial 88324340

GREEN BIOWORKS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
MICHOS, JOHN E
Law office
GENERIC WEB UPDATE

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GREEN BIOWORKS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Biological research, namely plant based biological research; Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical informationACTIVEDec 21, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 27, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 27, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 9, 2020WOAGWITHDRAWAL OF ATTORNEY GRANTED
Dec 9, 2020WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 6, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Oct 27, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 27, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 2, 2020GNSLLETTER OF SUSPENSION E-MAILED
Apr 2, 2020CNSLSUSPENSION LETTER WRITTEN
Sep 9, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 9, 2019GNSLLETTER OF SUSPENSION E-MAILED
Sep 9, 2019CNSLSUSPENSION LETTER WRITTEN
Aug 20, 2019DPCCDIVISIONAL PROCESSING COMPLETE
Aug 16, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 6, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2019INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Jul 16, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2019DRRRDIVISIONAL REQUEST RECEIVED
Jun 19, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED
May 20, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2019DOCKASSIGNED TO EXAMINER
Mar 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance